4//SEC Filing
Lubman Ellen 4
Accession 0000899243-23-001410
CIK 0001785530other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 9:36 PM ET
Size
10.2 KB
Accession
0000899243-23-001410
Insider Transaction Report
Form 4
Lubman Ellen
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2023-01-03+86,200→ 86,200 totalExercise: $2.05Exp: 2032-12-31→ Common Stock (86,200 underlying)
Footnotes (1)
- [F1]The option was granted on January 3, 2023 with a Vesting Commencement Date of January 1, 2023. The shares underlying the option vest in equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2027.
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
Related Parties
1- filerCIK 0001857842
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 9:36 PM ET
- Size
- 10.2 KB